Cargando…

Adherence to medication in neurogeriatric patients: an observational cross-sectional study

BACKGROUND: Poor adherence is a major issue and is associated with increased morbidity, mortality, and immense costs for the healthcare system. Due to demographic changes, the burden of neurological diseases is increasing with a crucial exacerbation of the problem of nonadherence. However, comprehen...

Descripción completa

Detalles Bibliográficos
Autor principal: Prell, Tino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664706/
https://www.ncbi.nlm.nih.gov/pubmed/31357968
http://dx.doi.org/10.1186/s12889-019-7353-5
_version_ 1783439939775496192
author Prell, Tino
author_facet Prell, Tino
author_sort Prell, Tino
collection PubMed
description BACKGROUND: Poor adherence is a major issue and is associated with increased morbidity, mortality, and immense costs for the healthcare system. Due to demographic changes, the burden of neurological diseases is increasing with a crucial exacerbation of the problem of nonadherence. However, comprehensive data on geriatric patients with neurological disorders do not exist to date. In this cross-sectional observational study we aim to identify disease-specific adherence-modulating factors in neurogeriatric patients. METHODS: Patients 60 years or older with neurological disorders will receive an assessment of adherence (Stendal Adherence with Medication Score) and a comprehensive geriatric assessment during their stay in the Department of Neurology or Geriatrics at the Jena University Hospital (baseline data). In addition disease specific data will be derived from medical records. After one and twelve months a telephone interview will be conducted to evaluate if and why changes of medication occurred (follow up data). DISCUSSION: This study aims to explore disease-specific patterns of nonadherence in elderly patients with neurological disorders and characteristics of information transfer between a specialized center, practicing neurologists, general practitioners, and the patients and their caregivers. This comprehensive data may help to develop and apply complex and disease-specific interventions to enhance adherence. TRIAL REGISTRATION: German Clinical Trials Register DRKS00016774. Registered 19.02.2019.
format Online
Article
Text
id pubmed-6664706
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66647062019-08-05 Adherence to medication in neurogeriatric patients: an observational cross-sectional study Prell, Tino BMC Public Health Study Protocol BACKGROUND: Poor adherence is a major issue and is associated with increased morbidity, mortality, and immense costs for the healthcare system. Due to demographic changes, the burden of neurological diseases is increasing with a crucial exacerbation of the problem of nonadherence. However, comprehensive data on geriatric patients with neurological disorders do not exist to date. In this cross-sectional observational study we aim to identify disease-specific adherence-modulating factors in neurogeriatric patients. METHODS: Patients 60 years or older with neurological disorders will receive an assessment of adherence (Stendal Adherence with Medication Score) and a comprehensive geriatric assessment during their stay in the Department of Neurology or Geriatrics at the Jena University Hospital (baseline data). In addition disease specific data will be derived from medical records. After one and twelve months a telephone interview will be conducted to evaluate if and why changes of medication occurred (follow up data). DISCUSSION: This study aims to explore disease-specific patterns of nonadherence in elderly patients with neurological disorders and characteristics of information transfer between a specialized center, practicing neurologists, general practitioners, and the patients and their caregivers. This comprehensive data may help to develop and apply complex and disease-specific interventions to enhance adherence. TRIAL REGISTRATION: German Clinical Trials Register DRKS00016774. Registered 19.02.2019. BioMed Central 2019-07-29 /pmc/articles/PMC6664706/ /pubmed/31357968 http://dx.doi.org/10.1186/s12889-019-7353-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Prell, Tino
Adherence to medication in neurogeriatric patients: an observational cross-sectional study
title Adherence to medication in neurogeriatric patients: an observational cross-sectional study
title_full Adherence to medication in neurogeriatric patients: an observational cross-sectional study
title_fullStr Adherence to medication in neurogeriatric patients: an observational cross-sectional study
title_full_unstemmed Adherence to medication in neurogeriatric patients: an observational cross-sectional study
title_short Adherence to medication in neurogeriatric patients: an observational cross-sectional study
title_sort adherence to medication in neurogeriatric patients: an observational cross-sectional study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664706/
https://www.ncbi.nlm.nih.gov/pubmed/31357968
http://dx.doi.org/10.1186/s12889-019-7353-5
work_keys_str_mv AT prelltino adherencetomedicationinneurogeriatricpatientsanobservationalcrosssectionalstudy